What is this study trying to find out about primary lung cancer and abdominal aortic aneurysm?

This study aims to understand how common abdominal aortic aneurysm (AAA) is in patients with primary lung cancer and to identify factors linking the two conditions. Researchers want to improve screening and prevention of AAA in lung cancer patients to support better treatment and long-term outcomes.

Who may be eligible for this primary lung cancer clinical trial?

Adults aged 20 to 90 years diagnosed with primary lung cancer may be eligible. Participants must be willing to have imaging tests of the abdominal aorta and able to participate in follow-up. This study accepts all genders. Please review eligibility criteria for more details.

Is there any cost to participate in this primary lung cancer clinical trial?

Study-related care, including imaging tests and all trial visits, is provided at no cost. However, personal travel or other expenses may vary and are not guaranteed to be covered.

Actively Recruiting

Age: 20Years - 90Years

All Genders

ID06775821

Study on Abdominal Aortic Aneurysm in Patients with Primary Lung Cancer A Multi-Center Prospective Investigation from 20 to 90 Years Old

Led by First Affiliated Hospital of Kunming Medical University · Updated on 2025-01-15

2000

Participants Needed

Research Sites

N/A

Total Duration

AI-Summary

What this Trial Is About

Researchers are investigating the relationship between abdominal aortic aneurysm AAA and primary lung cancer. Recent studies suggest many lung cancer cases are detected alongside AAA, but the exact incidence and mechanisms remain unclear. This study aims to provide detailed epidemiological data to improve screening, treatment, and long-term survival for lung cancer patients who may also have AAA. The study collects detailed information from 2000 to 3000 outpatients diagnosed with primary lung cancer between October 2022 and April 2025. Data include basic demographics, lifestyle habits, medical and family history, and laboratory tests. Participants undergo ultrasound or CT scans of the abdominal aorta to check for AAA. Researchers will analyze risk factors and follow patients long-term to understand the connection between lung cancer and AAA. Participants provide information through interviews and medical record reviews at two hospitals. Follow-up includes monitoring lung cancer progression, AAA presence, treatment details, and patient outcomes. Researchers measure the incidence of AAA in lung cancer patients and conduct epidemiological analyses. The study runs until April 2025, aiming to improve screening and prevention strategies for AAA in lung cancer patients.

CONDITIONS

Brief Title

Epidemiology of Abdominal Aortic Aneurysm With Concomitant Primary Lung Cancer

Who Can Participate

Age: 20Years - 90Years

All Genders

Eligibility Criteria

You may qualify if you...

Patients diagnosed with primary lung cancer through clinical or pathological examination

You will not qualify if you...

Patients diagnosed with primary lung cancer who refuse to undergo abdominal aortic imaging screening.

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - From October 2022 to April 2025

Participants undergo ultrasound or CT imaging of the abdominal aorta to detect the presence of abdominal aortic aneurysm.

1 to 2 visits depending on imaging schedule

Long-term Monitoring

Duration - Up to 2 years and 7 months

Participants provide detailed epidemiological data and undergo long-term follow-up to collect information on lung cancer and abdominal aortic aneurysm outcomes.

Periodic follow-up visits during the study period